Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-03CASI3Ownership Filing by Alexander ZukiwskiMEDIUM
This filing details the ownership of CASI Pharmaceuticals, Inc. by Alexander Zukiwski, the Global Chief Medical Officer. The filing, dated March 18, 2026, reports Zukiwski's direct ownership of various stock options. These options, all fully vested and exercisable, have an exercise price of $1.93 and an expiration date...
Nano CapBiotechnology
2026-04-02AUPH3Power of Attorney FilingMEDIUM
This filing details a Power of Attorney granted by Michael S. Hearne, Chief Financial Officer of Aurinia Pharmaceuticals Inc., to Stephen Robertson. The Power of Attorney authorizes Robertson to act on Hearne's behalf for all Section 16(a) and Rule 144 filings with the SEC, including obtaining EDGAR credentials, managi...
Mid CapBiotechnology
2026-04-02AUPH3Power of Attorney for SEC FilingsMEDIUM
This document is a Power of Attorney filed by Ryan Cole, Chief Operating Officer of Aurinia Pharmaceuticals Inc., appointing Stephen Robertson as his attorney-in-fact. This grants Mr. Robertson the authority to obtain credentials for submitting SEC filings via EDGAR, manage the EDGAR account, and execute Forms 3, 4, an...
Mid CapBiotechnology
2026-04-02Aurinia Pharmaceuticals Inc.3Power of Attorney for SEC FilingsDuplicateMEDIUM
This document is a Power of Attorney filed by Ryan Cole, Chief Operating Officer of Aurinia Pharmaceuticals Inc., appointing Stephen Robertson as his attorney-in-fact. This grants Mr. Robertson the authority to obtain credentials for submitting SEC filings via EDGAR, manage the EDGAR account, and execute Forms 3, 4, an...
Mid CapBiotechnology